Emmanuelle Waubant - Concepedia

Author

Emmanuelle Waubant

University of California, San Francisco ORCID

Also Known As

Amy Waldman, Antonio Uccelli, E Waubant, E. Waubant, Emmanuelle L Waubant, Emmanuelle L. Waubant, Emmanuelle Waubant, P. Descoins, S.S. Zamvil, Sandra Vukusic

494

Publications

45.8K

Citations

H-Index

191

Concepts

All Affiliations

University of California, San Francisco University of Utah University at Buffalo, State University of New York Massachusetts General Hospital Johns Hopkins University

About

Emmanuelle Waubant is an author at University of California, San Francisco specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	52	17.1K
2	Public Health	13	15	4.3K
3	Health Sciences	5	5	10K
4	Education	2	2	94
5	Management	1	1	68

Emmanuelle Waubant

188

Publications

32.4K

Citations

H-Index

Page 1

	Year	Citations
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria Chris H. Polman, Stephen C. Reingold, Brenda Banwell, Annals of Neurology Mcdonald CriteriaNeurological DisorderMedicineNeuroepidemiologyDiagnostic Criterion	2011	9.7K
Defining the clinical course of multiple sclerosis Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen, Neurology Neuroimaging BiomarkersSclerodermaNeurological DiseaseDisease ProgressionMedicine	2014	3K
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, New England Journal of Medicine	2008	2.4K
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial Kathleen Hawker, Paul O’Connor, Mark S. Freedman, Annals of Neurology	2009	924
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking Charlotte E. Teunissen, Axel Petzold, Jeffrey L. Bennett, Neurology DiagnosisNeurochemical BiomarkersCsf CollectionCerebrospinal Fluid CollectionBiomarker (Medicine)	2009	822
An open label study of the effects of rituximab in neuromyelitis optica Bruce Cree, Sara Lamb, Katherine A. Morgan, Neurology	2005	641
Incidental MRI anomalies suggestive of multiple sclerosis Darin T. Okuda, Ellen M. Mowry, A. Beheshtian, Neurology	2008	606
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial Amit Bar‐Or, Peter A. Calabresi, Douglas L. Arnold, Annals of Neurology	2008	524
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS? Amit Bar‐Or, Lama Fawaz, Boli Fan, Annals of Neurology	2009	509
T cell gelatinases mediate basement membrane transmigration in vitro. David Leppert, Emmanuelle Waubant, Richard E. Galardy, The Journal of Immunology	1995	502

Page 1